Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
Al-Sukaiti
Nashat
N
Reid
Brenda
B
Lavi
Sasson
S
Al-Zaharani
Daifulah
D
Atkinson
Adelle
A
Roifman
Chaim M
CM
Grunebaum
Eyal
E
D000293:Adolescent; D000553:Ambulatory Care; D000914:Antibodies, Viral / Q000097:blood; D018791:CD4 Lymphocyte Count; D002648:Child; D002675:Child, Preschool; D004062:DiGeorge Syndrome / Q000276:immunology*; D006801:Humans; D007407:Interviews as Topic; D008457:Measles / Q000517:prevention & control; D008459:Measles virus / Q000276:immunology; D022542:Measles-Mumps-Rubella Vaccine / Q000009:adverse effects* / Q000627:therapeutic use*; D009107:Mumps / Q000517:prevention & control; D009109:Mumps virus / Q000276:immunology; D012409:Rubella / Q000517:prevention & control; D012412:Rubella virus / Q000276:immunology; D013689:Telephone; D014611:Vaccination / Q000009:adverse effects; D055815:Young Adult
D000914:Antibodies, Viral; D022542:Measles-Mumps-Rubella Vaccine